anemodeanin A: RN given refers to (3beta)-isomer; from Anemone raddeana Regel; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
| Flora | Rank | Flora Definition | Family | Family Definition |
|---|---|---|---|---|
| Anemone | genus | A plant genus of the family RANUNCULACEAE that contains triterpene saponins. The root of Anemone raddeana is the source of a Chinese folk medicine, zhu jie xian fu. The common name of liverwort is also used with other plants. This genus is unrelated to SEA ANEMONES.[MeSH] | Ranunculaceae | The buttercup plant family of the order RANUNCULALES, class MAGNOLIOPSIDA. The leaves are usually alternate and stalkless. The flowers usually have two to five free sepals and may be radially symmetrical or irregular.[MeSH] |
| ID Source | ID |
|---|---|
| PubMed CID | 174742 |
| MeSH ID | M0142456 |
| Synonym |
|---|
| anemodeanin a |
| raddeanin a |
| 89412-79-3 |
| isolate from anemone raddeana regel |
| (4as,6ar,6as,6br,8ar,10s,12ar,14bs)-10-[(2s,3r,4s,5s)-3-[(2s,3r,4s,5s,6r)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2s,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-4,5-dihydroxyoxan-2-yl]oxy-2,2,6a,6b,9,9,12a-heptamethyl-1,3,4,5,6,6a,7,8,8a, |
| oleanolic acid 3-o-alpha-rhamnopyranosyl(1-2)-beta-glucopyranosyl(1-2)-alpha-arabinopyranoside |
| nsc 382873 |
| olean-12-en-28-oic acid, 3-((o-6-deoxy-alpha-l-mannopyranosyl-(1-2)-o-beta-d-glucopyranosyl-(1-2)-alpha-l-arabinopyranosyl)oxy)-, (3beta)- |
| S9262 |
| AC-35091 |
| Q-100879 |
| raddeanin-a |
| AKOS030573663 |
| HY-N0819 |
| raddeanin(anemodeanin) a |
| raddeanin r3 |
| CCG-270563 |
| CS-0009853 |
| MS-31672 |
| raddeanin(anemodeanin)a |
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 1 (3.45) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (3.45) | 29.6817 |
| 2010's | 14 (48.28) | 24.3611 |
| 2020's | 13 (44.83) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 1 (3.45%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 28 (96.55%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
| Article | Year |
|---|---|
| Suppression of eEF-2K-mediated autophagy enhances the cytotoxicity of raddeanin A against human breast cancer cells in vitro. Acta pharmacologica Sinica, Volume: 39, Issue: 4 | 2018 |
| [information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | |